Sender Gary
Insider CIK 1659085 · IBIO Director · SDGR Director · NBRV Chief Financial Officer · NBRV Chief Financial Officer · APMD Director · HRMY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | A Award deriv | 2026-10-14 | 2026-10-15 | 38,000 | — | $0 | 38,000 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 51,890 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 51,890 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2026-06-22 | 2026-06-23 | 13,313 | — | $0 | 13,313 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2026-06-22 | 2026-06-23 | 8,141 | — | $0 | 25,388 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2026-05-14 | 2026-05-18 | 21,872 | — | $0 | 21,872 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2025-11-20 | 2025-11-24 | 13,500 | — | $0 | 13,500 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 9,341 | — | $0 | 9,341 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2025-06-18 | 2025-06-20 | 5,997 | — | $0 | 17,247 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2025-05-15 | 2025-05-16 | 14,522 | — | $0 | 14,522 | SEC↗ |
| IBIO iBio, Inc. | P Buy | 2025-01-10 | 2025-01-13 | 9,191 | $2.72 | $25.0K | 9,191 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2024-11-21 | 2024-11-25 | 18,900 | — | $0 | 18,900 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 8,550 | — | $0 | 8,550 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2024-06-18 | 2024-06-20 | 5,000 | — | $0 | 11,250 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2024-05-29 | 2024-05-31 | 11,657 | — | $0 | 11,657 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2023-05-25 | 2023-05-26 | 9,613 | — | $0 | 48,255 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 14,907 | — | $0 | 14,907 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2022-05-20 | 2022-05-24 | 8,726 | — | $0 | 8,726 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2021-12-09 | 2021-12-13 | 109,000 | — | $0 | 109,000 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 8,736 | — | $0 | 8,736 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2021-05-20 | 2021-06-14 | 13,333 | — | $0 | 13,333 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise deriv | 2021-03-08 | 2021-03-10 | 12,890 | — | $0 | 19 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise deriv | 2021-03-08 | 2021-03-10 | 15,885 | — | $0 | 24,246 | SEC↗ |
| SDGR Schrodinger, Inc. | S Sale | 2021-03-08 | 2021-03-10 | 28,775 | $66.55 | $1.91M | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise | 2021-03-08 | 2021-03-10 | 12,890 | $17.00 | $219.1K | 28,775 | SEC↗ |
| SDGR Schrodinger, Inc. | M Exercise | 2021-03-08 | 2021-03-10 | 15,885 | $5.31 | $84.3K | 15,885 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-28 | 2021-03-02 | 31 | $2.39 | $74 | 20,472 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-01-31 | 2021-02-02 | 37 | $2.62 | $97 | 20,503 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-12-31 | 2021-01-05 | 32 | $2.42 | $77 | 20,540 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-11-30 | 2020-12-01 | 312 | $0.43 | $134 | 205,728 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-10-31 | 2020-11-02 | 312 | $0.50 | $156 | 206,040 | SEC↗ |
| IBIO iBio, Inc. | A Award deriv | 2020-10-14 | 2020-10-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 312 | $0.53 | $165 | 206,352 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 312 | $0.62 | $193 | 206,664 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-20 | 2020-08-21 | 3,204 | $0.65 | $2.1K | 206,976 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2020-08-19 | 2020-08-21 | 11,250 | — | $0 | 210,180 | SEC↗ |
| HRMY Harmony Biosciences Holdin | A Award deriv | 2020-08-18 | 2020-08-20 | 16,583 | — | $0 | 16,583 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 312 | $0.76 | $237 | 198,930 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 312 | $0.67 | $209 | 199,242 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 312 | $1.14 | $356 | 199,554 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 301 | $0.55 | $166 | 193,679 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 301 | $0.58 | $175 | 193,980 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 301 | $1.35 | $406 | 194,281 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2020-02-10 | 2020-02-10 | 12,909 | — | $0 | 12,909 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 210,000 | — | $0 | 210,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 105,000 | — | $0 | 183,669 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 4,295 | $1.35 | $5.8K | 78,669 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2019-08-21 | 2019-08-21 | 3,390 | $2.08 | $7.1K | 19,214 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2019-08-21 | 2019-08-26 | 3,390 | $2.08 | $7.1K | 19,214 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise | 2019-08-19 | 2019-08-21 | 11,250 | — | $0 | 22,604 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 138,200 | — | $0 | 138,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 52,500 | — | $0 | 52,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-05-23 | 2018-05-23 | 2,000 | $4.57 | $9.1K | 6,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-01-31 | 2018-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2017-09-22 | 2017-09-26 | 2,000 | $8.21 | $16.4K | 4,200 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-28 | 88,800 | — | $0 | 88,800 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-28 | 113,000 | — | $0 | 113,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other | 2017-06-23 | 2017-06-28 | 2,200 | — | $0 | 2,200 | SEC↗ |
| NBRV Nabriva Therapeutics AG | A Award deriv | 2017-02-07 | 2017-02-09 | 11,300 | — | $0 | 11,300 | SEC↗ |